IRIS Accounts Production v24.1.0.578 04495648 Board of Directors 1.8.22 31.7.23 31.7.23 false true false false false true false Ordinary 0.0100 iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh044956482022-07-31044956482023-07-31044956482022-08-012023-07-31044956482021-07-31044956482021-08-012022-07-31044956482022-07-3104495648ns15:EnglandWales2022-08-012023-07-3104495648ns14:PoundSterling2022-08-012023-07-3104495648ns10:Director12022-08-012023-07-3104495648ns10:PrivateLimitedCompanyLtd2022-08-012023-07-3104495648ns10:SmallEntities2022-08-012023-07-3104495648ns10:AuditExempt-NoAccountantsReport2022-08-012023-07-3104495648ns10:SmallCompaniesRegimeForDirectorsReport2022-08-012023-07-3104495648ns10:SmallCompaniesRegimeForAccounts2022-08-012023-07-3104495648ns10:FullAccounts2022-08-012023-07-310449564812022-08-012023-07-3104495648ns10:OrdinaryShareClass12022-08-012023-07-3104495648ns10:Director22022-08-012023-07-3104495648ns10:Director32022-08-012023-07-3104495648ns10:Director42022-08-012023-07-3104495648ns10:RegisteredOffice2022-08-012023-07-3104495648ns5:CurrentFinancialInstruments2023-07-3104495648ns5:CurrentFinancialInstruments2022-07-3104495648ns5:Non-currentFinancialInstruments2023-07-3104495648ns5:Non-currentFinancialInstruments2022-07-3104495648ns5:ShareCapital2023-07-3104495648ns5:ShareCapital2022-07-3104495648ns5:SharePremium2023-07-3104495648ns5:SharePremium2022-07-3104495648ns5:RetainedEarningsAccumulatedLosses2023-07-3104495648ns5:RetainedEarningsAccumulatedLosses2022-07-310449564812022-08-012023-07-3104495648ns5:ComputerSoftware2022-08-012023-07-3104495648ns5:PlantMachinery2022-08-012023-07-3104495648ns5:IntangibleAssetsOtherThanGoodwill2022-08-012023-07-3104495648ns5:IntangibleAssetsOtherThanGoodwill2023-07-3104495648ns5:FurnitureFittings2022-07-3104495648ns5:ComputerEquipment2022-07-3104495648ns5:FurnitureFittings2022-08-012023-07-3104495648ns5:ComputerEquipment2022-08-012023-07-3104495648ns5:FurnitureFittings2023-07-3104495648ns5:ComputerEquipment2023-07-3104495648ns5:FurnitureFittings2022-07-3104495648ns5:ComputerEquipment2022-07-3104495648ns5:CostValuation2022-07-3104495648ns5:CurrentFinancialInstrumentsns5:WithinOneYear2023-07-3104495648ns5:CurrentFinancialInstrumentsns5:WithinOneYear2022-07-3104495648ns5:Non-currentFinancialInstrumentsns5:MoreThanFiveYears2023-07-3104495648ns5:Non-currentFinancialInstrumentsns5:MoreThanFiveYears2022-07-3104495648ns5:Secured2023-07-3104495648ns5:Secured2022-07-3104495648ns10:OrdinaryShareClass12023-07-31
REGISTERED NUMBER: 04495648 (England and Wales)













UNAUDITED FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31 JULY 2023

FOR

ROADTOHEALTH GROUP LTD

ROADTOHEALTH GROUP LTD (REGISTERED NUMBER: 04495648)






CONTENTS OF THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 JULY 2023




Page

Company Information 1

Balance Sheet 2

Notes to the Financial Statements 4


ROADTOHEALTH GROUP LTD

COMPANY INFORMATION
FOR THE YEAR ENDED 31 JULY 2023







DIRECTORS: S D Embley
D R Moreau
A Reynolds
R S Verdin





REGISTERED OFFICE: 30 - 34 North Street
Hailsham
East Sussex
BN27 1DW





REGISTERED NUMBER: 04495648 (England and Wales)





ACCOUNTANTS: Watson Associates (Professional Services) Ltd
30 - 34 North Street
Hailsham
East Sussex
BN27 1DW

ROADTOHEALTH GROUP LTD (REGISTERED NUMBER: 04495648)

BALANCE SHEET
31 JULY 2023

2023 2022
Notes £    £   
FIXED ASSETS
Intangible assets 4 518,591 -
Tangible assets 5 6,466 1,473
Investments 6 7,046 7,046
532,103 8,519

CURRENT ASSETS
Debtors 7 178,039 153,198
Cash at bank 226,213 218,088
404,252 371,286
CREDITORS
Amounts falling due within one year 8 (973,873 ) (139,065 )
NET CURRENT (LIABILITIES)/ASSETS (569,621 ) 232,221
TOTAL ASSETS LESS CURRENT
LIABILITIES

(37,518

)

240,740

CREDITORS
Amounts falling due after more than one
year

9

(1,007,918

)

(947,918

)
NET LIABILITIES (1,045,436 ) (707,178 )

CAPITAL AND RESERVES
Called up share capital 11 7,754 7,754
Share premium 3,706,541 3,706,541
Retained earnings (4,759,731 ) (4,421,473 )
SHAREHOLDERS' FUNDS (1,045,436 ) (707,178 )

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 July 2023.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 July 2023 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

ROADTOHEALTH GROUP LTD (REGISTERED NUMBER: 04495648)

BALANCE SHEET - continued
31 JULY 2023


The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 30 July 2024 and were signed on its behalf by:





A Reynolds - Director


ROADTOHEALTH GROUP LTD (REGISTERED NUMBER: 04495648)

NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 JULY 2023

1. STATUTORY INFORMATION

Roadtohealth Group Ltd is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Preparation of consolidated financial statements
The financial statements contain information about Roadtohealth Group Ltd as an individual company and do not contain consolidated financial information as the parent of a group. The company is exempt under Section 399(2A) of the Companies Act 2006 from the requirements to prepare consolidated financial statements.

Critical accounting judgements and key sources of estimation uncertainty
No significant judgements have had to be made by management in preparing these financial statements.

There were no key assumptions made concerning the future, and other key sources of estimation uncertainty at the reporting date, that have a significant risk of causing a material adjustment to the carrying amounts of assets and liabilities within the next financial year.

Turnover
Turnover is measured at the fair value of the consideration received or receivable and represents amounts receivable services rendered, stated net of discounts and of Value Added Tax. When the consideration receivable in cash or cash equivalents is deferred, and the arrangement constitutes in effect a financing transaction, the fair value of the consideration is measured as the present value of all future receipts determined using an imputed rate of interest, normally the rate that discounts the nominal amount of consideration to the cash sales price.

The company recognises revenue when the amount of revenue can be measured reliably, when it
is probable that future economic benefits will flow to the entity.

ROADTOHEALTH GROUP LTD (REGISTERED NUMBER: 04495648)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 JULY 2023

2. ACCOUNTING POLICIES - continued

Software development
Development of products is capitalised where there is expected to be a benefit to future periods and the following conditions are met:

(i) It is technically feasible to complete the research and development so that the product will be available for use or sale

(ii) It is intended to use or sell the product being developed.

(iii) The Company is able to use or sell the product.

(iv) It can be demonstrated that the product will generate probable future economic benefits.

(v) Adequate technical, financial and other resources exist so that the product development can be competed and subsequently used or sold.

(vi) Expenditure attributable to the research and development work can be reliably measured.

Capitalised development expenditure is stated at cost less accumulated amortisation and impairment losses and amortised over it's economical useful life.

Amortisation begins when the intangible asset is available for use and is amortised over it's estimated useful life of 5 years.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.
Plant and machinery etc - 33% on cost

Investments in subsidiaries
Investments in subsidiary undertakings are recognised at cost.

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Hire purchase and leasing commitments
Rentals paid under operating leases are charged to profit or loss on a straight line basis over the period of the lease.

ROADTOHEALTH GROUP LTD (REGISTERED NUMBER: 04495648)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 JULY 2023

2. ACCOUNTING POLICIES - continued

Pension costs and other post-retirement benefits
The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

Going concern
At the balance sheet date, the company's net liabilities exceeded its net assets. The company has received assurance from the main creditors that this debt will not be called in unless sufficient funds are available at the time to repay the debt when it is due.

The company restructured during the year and new markets and revenue streams have opened that are expected to reverse the current position.

On this basis the directors consider it appropriate to prepare the accounts on the going concern

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 16 (2022 - 4 ) .

4. INTANGIBLE FIXED ASSETS
Other
intangible
assets
£   
COST
Additions 648,239
At 31 July 2023 648,239
AMORTISATION
Charge for year 129,648
At 31 July 2023 129,648
NET BOOK VALUE
At 31 July 2023 518,591

ROADTOHEALTH GROUP LTD (REGISTERED NUMBER: 04495648)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 JULY 2023

5. TANGIBLE FIXED ASSETS
Fixtures
and Computer
fittings equipment Totals
£    £    £   
COST
At 1 August 2022 - 4,568 4,568
Additions 2,337 6,355 8,692
At 31 July 2023 2,337 10,923 13,260
DEPRECIATION
At 1 August 2022 - 3,095 3,095
Charge for year 476 3,223 3,699
At 31 July 2023 476 6,318 6,794
NET BOOK VALUE
At 31 July 2023 1,861 4,605 6,466
At 31 July 2022 - 1,473 1,473

6. FIXED ASSET INVESTMENTS
Shares in
group
undertakings
£   
COST
At 1 August 2022
and 31 July 2023 7,046
NET BOOK VALUE
At 31 July 2023 7,046
At 31 July 2022 7,046

7. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2023 2022
£    £   
Trade debtors 111,647 105,094
Amounts owed by group undertakings - 1,770
Other debtors 66,392 46,334
178,039 153,198

8. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2023 2022
£    £   
Trade creditors 15,814 97,884
Amounts owed to group undertakings 857,025 -
Taxation and social security 77,254 37,171
Other creditors 23,780 4,010
973,873 139,065

ROADTOHEALTH GROUP LTD (REGISTERED NUMBER: 04495648)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 JULY 2023

9. CREDITORS: AMOUNTS FALLING DUE AFTER MORE THAN ONE
YEAR
2023 2022
£    £   
Other creditors 1,007,918 947,918

Amounts falling due in more than five years:

Repayable otherwise than by instalments
Debentures more 5yr non-instal 1,007,918 947,918

10. SECURED DEBTS

The following secured debts are included within creditors:

2023 2022
£    £   
Debentures 1,007,918 947,918

The debentures are secured by way of fixed and floating charges over the assets of the company.

The debentures have been restructured and are only repayable in case of default or in the event of a sale.

11. CALLED UP SHARE CAPITAL

Allotted, issued and fully paid:
Number: Class: Nominal 2023 2022
value: £    £   
7,754,469 Ordinary £0.00 1 7,754 7,754